|
|
The role of long non-coding RNA FENDRR in cervical cancer |
LAN Xiaoxiao, ZHOU Zhiyang, XU Xinxin, WU Xueqing |
Department of Gynaecology and Obstetrics, the First Affliated Hospital of Wenzhou Medical University, Wenzhou, 325015 |
|
Cite this article: |
LAN Xiaoxiao,ZHOU Zhiyang,XU Xinxin, et al. The role of long non-coding RNA FENDRR in cervical cancer[J]. JOURNAL OF WEZHOU MEDICAL UNIVERSITY, 2018, 48(4): 262-266.
|
|
Abstract Objective: To investigate the effects of long non-coding RNA FENDRR in cervical cancer. Methods: Cervical cancer cells were transfected with siRNA that specifically targeting FENDRR. QRT-PCR was used to verify the transfection effect of siRNA. Proliferation and motility capacities of cervical cancer cells were demonstrated by CCK-8 and Transwell assays, respectively. Tumorigenesis in nude mice was performed to identify the proliferation ability of cervical cancer cell in vivo. Results: With siRNA transfection, the expression levels of FENDRR in SiHa and HeLa were significantly reduced from (1.013±0.120), (1.001±0.025) to (0.226± 0.024), (0.099±0.010) (P<0.01). After transfecting with siRNA targeting FENDRR, the capacity of proliferation was significantly enhanced in cervical cancer cells (P<0.01), as well as migration and invasion abilities (P<0.01). The tumorigenesis in nude mice was obviously improved by interfering FENDRR expression in HeLa. Compared with the control group, the tumor volume increased from (853.2±59.4) mm3 to (1 155.0±51.5) mm3 (P<0.01), the tumor weight increased from (0.544±0.053) g to (0.814±0.061) g (P<0.05). Conclusion: Knockdown the expression of FENDRR in cervical cancer cells significantly enhanced their proliferation, migration as well as invasion abilities in vitro, and improved their tumorogenesis in vivo, which indicated that FENDRR may play an important inhibitory role in the progression of cervical cancer.
|
Received: 24 July 2017
|
|
|
|
|
[1] TORRE L A, BRAY F, SIEGEL R L, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015, 65(2): 87-108.
[2] KHALIL A M, GUTTMAN M, HUARTE M, et al. Many
human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression [J]. Proc Natl Acad Sci U S A, 2009, 106(28): 11667-11672.
[3] GROTE P, WITTLER L, HENDRIX D, et al. The tissue-specific lncRNA Fendrr is an essential regulator of heart and body wall development in the mouse[J]. Dev Cell, 2013, 24(2): 206-214.
[4] XU T P, HUANG M D, XIA R, et al. Decreased expression of the long non-coding RNA FENDRR is associated with poor prognosis in gastric cancer and FENDRR regulates gastric cancer cell metastasis by affecting fibronectin1 ex-pression[J]. J Hematol Oncol, 2014, 7: 63.
[5] DJEBALI S, DAVIS C A, MERKEL A, et al. Landscape of transcription in human cells[J]. Nature, 2012, 489(7414): 101-108.
[6] PRENSNER J R, CHINNAIYAN A M. The emergence of lncRNAs in cancer biology[J]. Cancer Discov, 2011, 1(5): 391-407.
[7] 孙祥威, 胡盈盈, 徐剑峰, 等. 长链非编码RNA AL049452在直肠癌组织中的表达及临床意义[J]. 温州医科大学学报, 2017, 47(8): 566-570.
[8] GUTTMAN M, AMIT I, GARBER M, et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals[J]. Nature, 2009, 458(7235): 223-227.
[9] HUARTE M, GUTTMAN M, FELDSER D, et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response[J]. Cell, 2010, 142(3): 409-419.
[10] ZHENG G X, DO B T, WEBSTER D E, et al. Dicer-microRNA-Myc circuit promotes transcription of hundreds of long noncoding RNAs[J]. Nat Struct Mol Biol, 2014, 21(7): 585-590.
[11] WANG K C, CHANG H Y. Molecular mechanisms of long noncoding RNAs[J]. Mol Cell, 2011, 43(6): 904-914.
[12] BUSSEMAKERS M J, VAN BOKHOVEN A, VERHAEGH G W, et al. DD3: a new prostate-specific gene, highly overexpressed in prostate cancer[J]. Cancer Res, 1999, 59(23): 5975-5979.
[13] WEI J T, FENG Z, PARTIN A W, et al. Can urinary PCA3 supplement PSA in the early detection of prostate cancer?[J]. J Clin Oncol, 2014, 32(36): 4066-4072.
[14] MIAO L, HUANG Z, ZENGLI Z, et al. Loss of long noncoding RNA FOXF1-AS1 regulates epithelial-mesenchymal transition, stemness and metastasis of non-small cell lung cancer cells[J]. Oncotarget, 2016, 7(42): 68339-68349.
[15] 徐然, 尚超, 石文君. 长链非编码RNA FENDRR对非小细胞肺癌细胞增殖及凋亡的影响[J]. 现代肿瘤医学, 2016, 24(17): 2667-2669.
[16] BRACKEN A P, DIETRICH N, PASINI D, et al. Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions[J]. Genes Dev, 2006, 20(9): 1123-1136.
[17] KU M, KOCHE R P, RHEINBAY E, et al. Genomewide analysis of PRC1 and PRC2 occupancy identifies two
classes of bivalent domains[J]. PLoS Genet, 2008, 4(10):
e1000242.
[18] SCHUETTENGRUBER B, CHOURROUT D, VERVOORT M, et al. Genome regulation by polycomb and trithorax pro-teins[J]. Cell, 2007, 128(4): 735-745.
[19] GUPTA R A, SHAH N, WANG K C, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis[J]. Nature, 2010, 464(7291): 1071-1076.
[20] GROTE P, HERRMANN B G. The long non-coding RNA Fendrr links epigenetic control mechanisms to gene regulatory networks in mammalian embryogenesis[J]. RNA Biol, 2013, 10(10): 1579-1585. |
|
|
|